Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This is a minor metadata change and does not affect study content or results.
    Difference
    0.1%
    Check dated 2026-02-13T13:53:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The only change is a version update from v3.4.0 to v3.4.1; no study content, eligibility criteria, or results were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:21:10.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Added UI controls for Show glossary and Hide glossary, and updated the page revision label to Revision: v3.4.0. Minor capitalization changes to 'Last Update Submitted' and 'No FEAR Act' text were applied.
    Difference
    0.4%
    Check dated 2026-01-22T17:38:57.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed; this seems to be metadata/versioning information rather than a substantive change to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:44:59.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added a dedicated 'Locations' section featuring the Colorado site. Removed the old 'Colorado Locations' entry and the 'HHS Vulnerability Disclosure' link from the footer.
    Difference
    0.2%
    Check dated 2025-12-17T20:17:39.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The PubMed publications note has been updated to say that publications are automatically filled from PubMed and may not be about the study. The revision label has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T08:41:14.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.